Research Design Service: West Midlands
« back

NIHR EME Application Acceleration Award – International platform studies in precision medicine

  Monday, 18 Jul 2022 | Funding Deadline

The Efficacy and Mechanism Evaluation (EME) Programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. Within these studies, EME supports research in the mechanisms of diseases and treatments. EME is a partnership between the Medical Research Council (MRC) and the NIHR.

The MRC-EME Programme is accepting straight to Stage 2 applications to their commissioned workstream for large, ambitious platform studies which efficiently evaluate multiple interventions, with a particular interest in those taking a precision medicine approach. Studies with international collaborations, involving recruitment in other countries to a common protocol, will be particularly welcome where this will benefit the study. A precision medicine platform is defined as a study which incorporates the evaluation of more than one intervention or technology within a single protocol, which takes account of interindividual variability when determining eligibility and stratifying participants.

The programme hopes to fund multiple platforms that are able to commence from April 2024.

Deadline for proposals: 18 July 2022
Find out more here